The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I think 4D should release Blautix to market without phase 3. It will be classed as a probiotic supplement instead of a medical treatment, the IBS market will decide if it works or not. Just my opinion.
Well it looks like Intertrader have today taken themselves below the 3% TR1 threshold by selling a negligible amount of shares. I'm trying to think why they would do that unless they are intending to gradually sell off further shares without spooking the market.
Any thoughts welcome.
I have a feeling it was a 3.3million buy and I also think it was intended to be much larger but the MMs had trouble scaring enough people into selling. I guess we'll find out tomorrow morning.
I noticed the MMs were trying very hard to grab shares today:
- At 1.4p, they weren't allowing buys most of the time, only sells.
- When people eventually managed to buy, the spread was widened to something stupid like 1.40-1.55p.
- My buy probably won't appear until tomorrow, it hasn't shown up on L2.
Fun day.
Yeah, the bot is bringing it down.
Agreed, I followed this share up and there was good support around 90p and also 77-80p.
Could be stop losses I guess and MMs triggering but strange looking.
Every time the price moves rapidly, L2 shows a big stack of automated trades. Be aware it looks like a machine dictates where the SP goes, it seems like it's working to gradually clear out holders.
If they try to raid stop losses in the 90's, it'll be a good time to buy in my opinion. Plenty of buying around the 100p mark.
I'm looking at L2, lots of buys and MMs dropping prices. Tree shake imo.
@RichKen I really hope that 4D would see past a mere $2bn offer. $20bn+ would be a more accurate representation of the future worth of this business if live biotherapeutics are proven and 4D's current portfolio of approximately 1000 patented bacterial strains are taken into consideration.
In my opinion, 4D are indicating the Blautix results are a success, I'm hoping the delay in results is due to negotiations with interested parties. We'll see what happens with the SP, it's prone to moving very rapidly as it did on the 25th September so don't rule out a rise later today as the market digests today's RNS.
I like how they've explicitly written that the interim phase 2 Blautix results were purely a futility study, this should put an end to speculation.
If you arrange this spreadsheet by trade value, you'll see a large £195,569.24 trade from yesterday has only just been reported today:
https://api.londonstockexchange.com/api/gw/lse/download/DDDD/trades
I wonder if they have crashed the price to make a large after-hours buy. I will post back if I find anything.
What are peoples' thoughts on the likelihood of RNS tomorrow? I've seen emails people have posted to Twitter purporting to be from 4D Pharma investor relations stating that they are on track to deliver results in Q3 i.e. tomorrow:
https://twitter.com/JordanBMZ/status/1308397291540295681
With any luck, could get a FOMO rise before close today. I'm just wondering how the results could be anything less than positive since IBS should be the easiest condition for a microbiome company to treat, the Phase 1 trial showed evidence of efficacy, phase 2 interims were deemed not futile and we have supposed trial participants on Reddit stating they experienced significant improvements.
As always guys, do your own research and know the risks.
It shot back up so either MMs filled a large buy order or a lot of people had automated buy orders at that level. Either way, this stock has good support.
Ouch! Double ouch!